Zemplar
Showing 1 - 25 of 86
Untreated Metastatic Pancreatic Ductal Adenocarcinoma Trial in Scottsdale (Nivolumab, Albumin-bound paclitaxel, Paricalcitol)
Active, not recruiting
- Untreated Metastatic Pancreatic Ductal Adenocarcinoma
- Nivolumab
- +4 more
-
Scottsdale, ArizonaHonorHealth Research Institute
Feb 15, 2022
Resectable Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Scottsdale (Paclitaxel Protein
Active, not recruiting
- Resectable Pancreatic Cancer
- +3 more
- Paclitaxel Protein Bound (Abraxane)
-
Scottsdale, ArizonaHonorHealth Research Institute
Feb 15, 2022
Pancreatic Cancer, Pancreas Adenocarcinoma, Advanced Pancreatic Cancer Trial in United States (Pembrolizumab, paricalcitol, )
Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Scottsdale (Paricalcitol (Zemplar))
Active, not recruiting
- Pancreatic Cancer
- +4 more
- Paricalcitol (Zemplar)
-
Scottsdale, ArizonaHonorHealth Research Institute
Feb 16, 2022
Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta
Recruiting
- Advanced Pancreatic Adenocarcinoma
- +2 more
- Gemcitabine
- +3 more
-
Atlanta, Georgia
- +2 more
Feb 28, 2022
Moderate to Severe Secondary Hyperparathyroidism, Stage 5 Chronic Kidney Diseases Trial (Paricalcitol, Darbepoetin alfa)
Completed
- Moderate to Severe Secondary Hyperparathyroidism
- Stage 5 Chronic Kidney Diseases
- Paricalcitol
- Darbepoetin alfa
- (no location specified)
Jul 28, 2021
Pancreatic Cancer, Pancreas Cancer, Cancer of the Pancreas Trial in Saint Louis (5-FU, Leucovorin, Liposomal Irinotecan)
Active, not recruiting
- Pancreatic Cancer
- +2 more
- 5-FU
- +5 more
-
Saint Louis, MissouriWashington University School of Medicine
Sep 29, 2021
Resectable Pancreatic Carcinoma, Stage I Pancreatic Cancer AJCC v6 and v7, Stage IA Pancreatic Cancer AJCC v6 and v7 Trial in
Active, not recruiting
- Resectable Pancreatic Carcinoma
- +6 more
- Gemcitabine Hydrochloride
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Aug 16, 2022
Vitamin D Receptor Activator Therapy in Stage 3/4 CKD Patients
Completed
- CKD Stage 3/4
- Vitamin D 2mg daily for 2 weeks oral paricalcitol
- Placebo
-
Chicago, IllinoisUniversity of Illinois at Chicago
Aug 13, 2020
Hypophosphatemia, Familial, Hyperparathyroidism Trial in New Haven (Paricalcitol, Placebo)
Completed
- Hypophosphatemia, Familial
- Hyperparathyroidism
- Paricalcitol
- Placebo
-
New Haven, ConnecticutYale University School of Medicine
Mar 3, 2020
Chronic Pancreatitis Trial in Los Angeles (Paricalcitol, Placebo)
Not yet recruiting
- Chronic Pancreatitis
- Paricalcitol
- Placebo
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Dec 16, 2022
Hypersensitivity Trial in Amsterdam (Paricalcitol, Placebo (for paricalcitol))
Completed
- Hypersensitivity
- Paricalcitol
- Placebo (for paricalcitol)
-
Amsterdam, NetherlandsAcademic medical center
Aug 31, 2018
Metastatic Cancer, Prostate Cancer Trial in Winston-Salem (drug, other, procedure)
Terminated
- Metastatic Cancer
- Prostate Cancer
- paricalcitol
- +4 more
-
Winston-Salem, North CarolinaWake Forest University Comprehensive Cancer Center
Jul 3, 2018
Chronic Kidney Disease Stage 3 and 4 Trial (Paricalcitol, Placebo)
Completed
- Chronic Kidney Disease Stage 3 and 4
- Paricalcitol
- Placebo
- (no location specified)
Jun 1, 2018
End-Stage Renal Disease, Secondary Hyperparathyroidism Trial (paricalcitol)
Completed
- End-Stage Renal Disease
- Secondary Hyperparathyroidism
- (no location specified)
Jun 1, 2018
Secondary Hyperparathyroidism Due to Renal Causes Trial in Spain (Paricalcitol, Calcifediol)
Completed
- Secondary Hyperparathyroidism Due to Renal Causes
-
Badalona, Barcelona, Spain
- +15 more
May 18, 2018
Mucinous Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer, Stage IIB Rectal Cancer Trial in Winston-Salem (drug, radiation,
Terminated
- Mucinous Adenocarcinoma of the Rectum
- +5 more
- paricalcitol
- +3 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jun 29, 2018
Disorder of Transplanted Kidney, Proteinuria, Albuminuria Trial in Ljubljana (Paricalcitol, Placebo)
Completed
- Disorder of Transplanted Kidney
- +2 more
- Paricalcitol
- Placebo
-
Ljubljana, SloveniaUniversity Medical Centre Ljubljana
Dec 22, 2017
Chronic Kidney Disease, Vitamin D Deficiency, Coronary Calcification Trial in Philadelphia (Calcitriol (Rocaltrol®),
Completed
- Chronic Kidney Disease
- +3 more
- Calcitriol (Rocaltrol®)
- Paricalcitol
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Dec 7, 2017
Breast Cancer Trial in Winston-Salem (docetaxel, ixabepilone, paclitaxel)
Completed
- Breast Cancer
- docetaxel
- +4 more
-
Winston-Salem, North CarolinaWake Forest University Comprehensive Cancer Center
May 25, 2017
Endstage Renal Disease, Secondary Hyperparathyroidism Trial in Hong Kong (Intravenous Paricalcitol)
Unknown status
- Endstage Renal Disease
- Secondary Hyperparathyroidism
- Intravenous Paricalcitol
-
Hong Kong, Hong KongQueen Mary Hospital and Tung Wah Hospital
Jan 14, 2017
Kidney Failure, Secondary Hyperparathyroidism, Hyperphosphatemia Trial in Mineola (Calcitriol, Paricalcitol)
Terminated
- Kidney Failure
- +3 more
-
Mineola, New YorkWinthrop University Hospital
Jan 11, 2016
Secondary Hyperparathyroidism Trial in United States (Hectorol (doxercalciferol capsules), Zemplar (paricalcitol injection))
Completed
- Secondary Hyperparathyroidism
- Hectorol (doxercalciferol capsules)
- Zemplar (paricalcitol injection)
-
Downey, California
- +7 more
May 4, 2015
Secondary Hyperparathyroidism Trial in Minneapolis (Hectorol (doxercalciferol injection), Zemplar (Paricalcitol injection))
Completed
- Secondary Hyperparathyroidism
- Hectorol (doxercalciferol injection)
- Zemplar (Paricalcitol injection)
-
Minneapolis, Minnesota(unnamed)
May 4, 2015